|
|
|
Insider
Information: |
Orbimed Capital Gp Vi Llc |
Relationship: |
Director, 10% Owner |
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
17 |
|
Direct
Shares |
5,826,224 |
|
Indirect Shares
|
46,949,846 |
|
|
Direct
Value |
$193,255,850 |
|
|
Indirect Value
|
$504,861,587 |
|
|
Total
Shares |
52,776,070 |
|
|
Total
Value |
$698,117,437 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
16
|
Stock
price went up :
|
0
|
1
|
Stock
price went down : |
0
|
15
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-513.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Synlogic Inc |
SYBX |
Director |
|
0 |
2021-04-20 |
3,696,662 |
Premium* |
|
Kala Pharmaceuticals, Inc. |
KALA |
10% Owner |
2018-01-12 |
0 |
2018-02-08 |
3,447,840 |
Premium* |
|
Adicet Bio, Inc |
ACET |
Director, 10% Owner |
2018-01-30 |
0 |
2018-01-30 |
4,830,387 |
Premium* |
|
Constellation Pharmaceuticals Inc |
CNST |
10% Owner |
2018-07-23 |
0 |
2018-07-23 |
417,921 |
Premium* |
|
Alpine Immune Sciences Inc |
ALPN |
Director, 10% Owner |
2019-01-18 |
0 |
2020-12-28 |
3,070,955 |
Premium* |
|
Turning Point Therapeutics, Inc. |
TPTX |
Director |
2019-04-22 |
0 |
2019-04-22 |
2,027,550 |
Premium* |
|
Nextcure, Inc. |
NXTC |
Director, 10% Owner |
2019-05-13 |
0 |
2019-05-13 |
2,711,013 |
Premium* |
|
Prevail Therapeutics Inc. |
PRVL |
Director, 10% Owner |
|
0 |
2021-01-22 |
0 |
Premium* |
|
Springworks Therapeutics, Inc. |
SWTX |
10% Owner |
2019-09-17 |
0 |
2022-09-12 |
5,599,842 |
Premium* |
|
Cti Biopharma Corporation |
CTIC |
10% Owner |
|
0 |
2021-01-07 |
7,520,600 |
Premium* |
|
Oric Pharmaceuticals, Inc. |
ORIC |
Director |
2020-04-24 |
0 |
2021-03-30 |
2,212,571 |
Premium* |
|
Prelude Therapeutics Inc |
PRLD |
Director, 10% Owner |
|
0 |
2020-09-24 |
206,912 |
Premium* |
|
Calcimedica Ord Shs |
CALC |
10% Owner |
2020-09-25 |
0 |
2020-09-29 |
4,163,347 |
Premium* |
|
Silverback Therapeutics, Inc. |
SBTX |
Director, 10% Owner |
|
0 |
2020-12-03 |
538,646 |
Premium* |
|
Disc Medicine, Inc |
IRON |
Director, 10% Owner |
2021-02-05 |
5,826,224 |
|
0 |
Premium* |
|
Neuropace Inc |
NPCE |
10% Owner |
2021-04-21 |
0 |
2024-05-03 |
3,406,335 |
Premium* |
|
Turnstone Biologics Corp. |
TSBX |
Director, 10% Owner |
2023-07-20 |
0 |
2023-07-20 |
3,099,265 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
84 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ORIC |
Oric Pharmaceuticals, Inc... |
Director |
|
2021-03-15 |
4 |
AS |
$29.14 |
$2,599,579 |
I/I |
(89,210) |
2,527,435 |
0 |
- |
|
ORIC |
Oric Pharmaceuticals, Inc... |
Director |
|
2021-03-12 |
4 |
AS |
$30.29 |
$2,741,881 |
I/I |
(90,521) |
2,616,645 |
0 |
- |
|
TSBX |
Turnstone Biologics Corp. |
Director |
|
2023-07-20 |
4 |
A |
$0.00 |
$0 |
I/I |
2,682,599 |
2,682,599 |
0 |
- |
|
ORIC |
Oric Pharmaceuticals, Inc... |
Director |
|
2021-03-11 |
4 |
AS |
$33.04 |
$1,934,525 |
I/I |
(58,551) |
2,707,166 |
0 |
- |
|
NXTC |
Nextcure, Inc. |
Director |
|
2019-05-13 |
4 |
B |
$15.00 |
$5,250,000 |
I/I |
350,000 |
2,711,013 |
2.25 |
- |
|
KALA |
Kala Pharmaceuticals, Inc... |
10% Owner |
|
2018-01-12 |
4 |
B |
$14.50 |
$556,133 |
I/I |
38,354 |
2,731,069 |
1.5 |
- |
|
ORIC |
Oric Pharmaceuticals, Inc... |
Director |
|
2020-04-28 |
4 |
A |
$0.00 |
$0 |
I/I |
2,484,467 |
2,765,717 |
0 |
- |
|
KALA |
Kala Pharmaceuticals, Inc... |
10% Owner |
|
2018-01-19 |
4 |
B |
$14.95 |
$1,120,218 |
I/I |
74,931 |
2,806,000 |
1.5 |
- |
|
KALA |
Kala Pharmaceuticals, Inc... |
10% Owner |
|
2018-01-22 |
4 |
B |
$14.98 |
$1,123,500 |
I/I |
75,000 |
2,881,000 |
1.5 |
- |
|
KALA |
Kala Pharmaceuticals, Inc... |
10% Owner |
|
2018-01-23 |
4 |
B |
$14.99 |
$65,401 |
I/I |
4,363 |
2,885,363 |
1.5 |
- |
|
KALA |
Kala Pharmaceuticals, Inc... |
10% Owner |
|
2018-01-24 |
4 |
B |
$14.91 |
$963,738 |
I/I |
64,637 |
2,950,000 |
1.5 |
- |
|
KALA |
Kala Pharmaceuticals, Inc... |
10% Owner |
|
2018-01-26 |
4 |
B |
$14.93 |
$339,807 |
I/I |
22,760 |
2,972,760 |
1.5 |
- |
|
KALA |
Kala Pharmaceuticals, Inc... |
10% Owner |
|
2018-01-29 |
4 |
B |
$14.99 |
$749,500 |
I/I |
50,000 |
3,022,760 |
1.5 |
- |
|
ALPN |
Alpine Immune Sciences In... |
Director |
|
2020-12-28 |
4 |
S |
$14.25 |
$8,550,000 |
I/I |
(600,000) |
3,070,955 |
0 |
% |
|
TSBX |
Turnstone Biologics Corp. |
Director |
|
2023-07-20 |
4 |
B |
$12.00 |
$4,999,992 |
I/I |
416,666 |
3,099,265 |
2.25 |
- |
|
KALA |
Kala Pharmaceuticals, Inc... |
10% Owner |
|
2018-01-31 |
4 |
B |
$15.00 |
$5,091,000 |
I/I |
339,400 |
3,362,160 |
1.5 |
- |
|
KALA |
Kala Pharmaceuticals, Inc... |
10% Owner |
|
2018-02-01 |
4 |
B |
$14.99 |
$342,372 |
I/I |
22,840 |
3,385,000 |
1.5 |
- |
|
NPCE |
Neuropace Inc |
10% Owner |
|
2024-05-03 |
4 |
S |
$14.03 |
$65,576 |
I/I |
(4,674) |
3,406,335 |
0 |
% |
|
NPCE |
Neuropace Inc |
10% Owner |
|
2024-05-02 |
4 |
S |
$14.01 |
$123,876 |
I/I |
(8,842) |
3,411,009 |
0 |
% |
|
NPCE |
Neuropace Inc |
10% Owner |
|
2024-05-01 |
4 |
S |
$14.02 |
$219,974 |
I/I |
(15,690) |
3,419,851 |
0 |
% |
|
KALA |
Kala Pharmaceuticals, Inc... |
10% Owner |
|
2018-02-02 |
4 |
B |
$14.73 |
$557,383 |
I/I |
37,840 |
3,422,840 |
1.5 |
- |
|
NPCE |
Neuropace Inc |
10% Owner |
|
2024-04-24 |
4 |
S |
$14.06 |
$25,041 |
I/I |
(1,781) |
3,435,541 |
0 |
% |
|
NPCE |
Neuropace Inc |
10% Owner |
|
2024-04-23 |
4 |
S |
$14.29 |
$311,393 |
I/I |
(21,791) |
3,437,322 |
0 |
% |
|
KALA |
Kala Pharmaceuticals, Inc... |
10% Owner |
|
2018-02-08 |
4 |
B |
$12.93 |
$323,250 |
I/I |
25,000 |
3,447,840 |
1.5 |
- |
|
NPCE |
Neuropace Inc |
10% Owner |
|
2024-04-22 |
4 |
S |
$14.05 |
$345,756 |
I/I |
(24,609) |
3,459,113 |
0 |
% |
|
84 Records found
|
|
Page 2 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|